| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Iovance Biotherapeutics, Inc. (IOVA) has 12 insiders with recent SEC Form 4 filings, including 4 buys and 6 sells. IOVA is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 235.0K | $850.7K | - | |
| Dir | 135.1K | $489.0K | - | |
| Other | 132.2K | $478.6K | - | |
| CFO | 132.2K | $478.6K | - | |
| Other | 117.5K | $425.4K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Dec 18, 2018 | Dukes Iain D. | Director | Buy | 12,000 | $8.65 | $103,796.40 | New | |
| Dec 13, 2018 | McPeak Merrill A55 | Director | Buy | 10,000 | $9.63 | $96,273.00 | +2.2% | |
| Dec 6, 2018 | Rothbaum Wayne P.60 | Director | Buy | 1,221,053 | $10.20 | $12,454,056.43 | +9.7% | |
| Aug 22, 2016 | Hillsberg Sanford | Director | Sell | 54,000 | $9.11 | $491,740.20 | -35.1% | |
| Sep 8, 2015 | Hillsberg Sanford | Director | Sell | 32,500 | $6.99 | $227,085.00 | -9.1% | |
| Aug 3, 2015 | Hillsberg Sanford | Director | Sell | 32,500 | $8.15 | $264,875.00 | -14.8% | |
| May 6, 2015 | Hillsberg Sanford | Director | Sell | 50,000 | $10.00 | $500,000.00 | -18.6% | |
| May 1, 2015 | Ayer Capital Management, LP | 10% Owner | Sell | 2,780,682 | $9.62 | $26,752,385.39 | -49.6% |